Sp1074

OPTIMIZING ENDOSCOPIC EVALUATION IN BARRETT'S ESOPHAGUS AND REDUCING PEEC/PEEN IN CLINICAL PRACTICE

Date
May 21, 2024

Presenter

Speaker Image for Sachin Wani
University of Colorado

Tracks

Related Products

Thumbnail for AGA GUIDELINE: ENDOSCOPIC MANAGEMENT OF BARRETT'S ESOPHAGUS Q&A
Thumbnail for DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING (ML) BASED DECISION-MAKING TOOL TO DETERMINE RISK AND TIMING OF RECURRENCE OF BARRETT’S ESOPHAGUS (BE) NEOPLASIA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET)
DEVELOPMENT AND VALIDATION OF A MACHINE LEARNING (ML) BASED DECISION-MAKING TOOL TO DETERMINE RISK AND TIMING OF RECURRENCE OF BARRETT’S ESOPHAGUS (BE) NEOPLASIA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET)
Recent studies have described the durability of EET for BE-related neoplasia and the risk of neoplastic recurrence after achieving complete eradication of intestinal metaplasia (CE-IM). Current guidelines for endoscopic surveillance intervals post-EET are based on limited evidence…
Thumbnail for Esophageal, Gastric & Duodenal Disorders (EGD) Section Distinguished Abstract Plenary
Esophageal, Gastric & Duodenal Disorders (EGD) Section Distinguished Abstract Plenary
SOCIETY: AGA Looking into the crystal ball: novel diagnostic and therapeutic paradigms in foregut disorders
Thumbnail for LOW INCIDENCE OF RECURRENT NEOPLASTIC BARRETT’S ESOPHAGUS (BE) AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET): LONG-TERM OUTCOMES FROM A MULTICENTER PROSPECTIVE COHORT STUDY
LOW INCIDENCE OF RECURRENT NEOPLASTIC BARRETT’S ESOPHAGUS (BE) AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY (EET): LONG-TERM OUTCOMES FROM A MULTICENTER PROSPECTIVE COHORT STUDY
INTRODUCTION: EET is endorsed by guidelines for treatment of BE-related neoplasia patients. Few studies describe long-term durability outcomes in BE patients who achieve complete eradication of intestinal metaplasia (CE-IM) following EET…